Factors associated with the use of medicines and self-medication during the COVID-19 pandemic in 12 Latin American countries

Author:

Mejia Christian R.ORCID,Ruiz-Aquino MelyORCID,Garcia-Arteta GianelaORCID,Ramos GinORCID,Astete-Pérez IsabelORCID,Pineda-Cáceres MarianaORCID,Collahua-Briceño MariluzORCID,Vargas-Patiño Katherine,Arias-Chávez Dennis,Franchi ThomasORCID,Pedersini Paolo,Tovani-Palone Marcos RobertoORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference22 articles.

1. Weekly Epidemiological Update on COVID-19-31 August 2021;World Health Organization (WHO),2021

2. Socioeconomic conditioning of the development of the COVID-19 pandemic and its global spatial differentiation;Bański;Int. J. Environ. Res. Publ. Health,2021

3. On New Recommendation for Treatment of COVID-19 Patients: WHO Calls for Equitable Access to Casirivimab and Imdevimab for COVID-19,2021

4. WHO Adds Regeneron Drug to Recommended Covid-19 Treatments, but Criticizes its Pricing;Silverman,2021

5. Prescription, over-the-counter (OTC), herbal, and other treatments and preventive uses for COVID-19;Yáñez,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3